Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5Triple Negative Breast Neoplasms 4Neoplasm Metastasis 4Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Neuroblastoma 3Melanoma 3Lung Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Oligodendroglioma 2Neoplasms 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Gliosarcoma 2Glioma 2Glioblastoma 2Carcinoma, Renal Cell 2Brain Neoplasms 2Astrocytoma 2Advanced Malignant Solid Tumor 2Adenoma, Islet Cell 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rhabdoid Tumor 1Resectable Pancreatic Cancer 1

Interventions

Gemcitabine 3folfirinox 2Cisplatin 2paricalcitol 1nimotuzumab 1Taxes 1Granulocyte-Macrophage Colony-Stimulating Factor 1Colony-Stimulating Factors 1Chemotherapy, Adjuvant 1Chemoradiotherapy, Adjuvant 1Albumin-Bound Paclitaxel 1Adjuvants, Immunologic 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Resectable Pancreatic Cancer × Colony-Stimulating Factors × Clear all
NCT04810910 2021-11-16

Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Zhejiang Provincial People's Hospital

Phase 1 Unknown
20 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡